Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody
出版年份 2012 全文链接
标题
Preclinical Efficacy and Immunological Safety of FR104, an Antagonist Anti-CD28 Monovalent Fab′ Antibody
作者
关键词
-
出版物
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 12, Issue 10, Pages 2630-2640
出版商
Wiley
发表日期
2012-07-04
DOI
10.1111/j.1600-6143.2012.04164.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion
- (2014) A.-S. Dugast et al. JOURNAL OF IMMUNOLOGY
- The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation
- (2014) W. Chen et al. JOURNAL OF IMMUNOLOGY
- CD28-Specific Immunomodulating Antibodies: What Can Be Learned From Experimental Models?
- (2012) N. Poirier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Murine Regulatory T Cells Contain Hyperproliferative and Death-Prone Subsets with Differential ICOS Expression
- (2012) Y. Chen et al. JOURNAL OF IMMUNOLOGY
- Selective CD28 Blockade Attenuates Acute and Chronic Rejection of Murine Cardiac Allografts in a CTLA-4-Dependent Manner
- (2011) T. Zhang et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice
- (2011) Jun Li et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling
- (2011) K. Semple et al. BLOOD
- B7-H2 Is a Costimulatory Ligand for CD28 in Human
- (2011) Sheng Yao et al. IMMUNITY
- Sustained suppression by Foxp3+regulatory T cells is vital for infectious transplantation tolerance
- (2011) Adrian R. Kendal et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Belatacept
- (2011) Flavio Vincenti et al. NATURE REVIEWS DRUG DISCOVERY
- A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
- (2010) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells
- (2010) D Eastwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alternatives to calcineurin inhibition in renal transplantation: belatacept, the first co-stimulation blocker
- (2010) Nicolas Poirier et al. Immunotherapy
- Relative Over-Reactivity of Human versus Chimpanzee Lymphocytes: Implications for the Human Diseases Associated with Immune Activation
- (2010) P. C. Soto et al. JOURNAL OF IMMUNOLOGY
- Inducing CTLA-4-Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation
- (2010) N. Poirier et al. Science Translational Medicine
- A more selective costimulatory blockade of the CD28-B7 pathway
- (2010) Nicolas Poirier et al. TRANSPLANT INTERNATIONAL
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
- (2009) Karl S. Peggs et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412
- (2009) Lucy Findlay et al. JOURNAL OF IMMUNOLOGICAL METHODS
- FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft Model
- (2008) Siba P. Raychaudhuri et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interaction of human PD-L1 and B7-1
- (2008) Manish J. Butte et al. MOLECULAR IMMUNOLOGY
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
- A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene
- (2007) Marie King et al. CLINICAL IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started